News

McGill University joins Phase II efficacy trial

McGill University Health Centre in Montreal is one of the leading academic health centres in the world. They will be participating in the Phase II trial to enroll and treat Patients with Non-Muscle Invasive Bladder Cancer. See the Theralase press release for more details.